BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25799154)

  • 41. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer.
    Li J; Chen P; Li XQ; Bao QL; Dai CH; Ge LP
    Int J Cancer; 2013 Mar; 132(5):1098-104. PubMed ID: 22930255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
    Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer].
    Gao J; Wang H; Qi J
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):930-2. PubMed ID: 19173996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.
    Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G
    Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic role of liquid-based cytology of bronchial lavage fluid in addition to bronchial brushing specimens in lung cancer.
    Cao C; Yu X; Zhu T; Jiang Q; Li Y; Li X
    Tumori; 2021 Aug; 107(4):325-328. PubMed ID: 32972322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer.
    Zhou Q; Yang Z; Yang J; Tian Z; Zhang H
    J Surg Oncol; 1992 Jun; 50(2):121-4. PubMed ID: 1317485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to express tumor markers in bronchoalveolar lavage.
    Gómez de Terreros Caro FJ; Alvarez-Sala R; Prados MC; Callol L; Gómez de Terreros Sánchez FJ; Villamor J
    Int J Biol Markers; 2004; 19(1):67-71. PubMed ID: 15077929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance and prognostic value of pentraxin-3 as serologic biomarker for lung cancer.
    Zhang D; Ren WH; Gao Y; Wang NY; Wu WJ
    Asian Pac J Cancer Prev; 2013; 14(7):4215-21. PubMed ID: 23991979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of tumor in bronchial biopsy specimens.
    Coghlin CL; Smith LJ; Bakar S; Stewart KN; Devereux GS; Nicolson MC; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):448-52. PubMed ID: 20125040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
    Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
    J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
    Pio R; Garcia J; Corrales L; Ajona D; Fleischhacker M; Pajares MJ; Cardenal F; Seijo L; Zulueta JJ; Nadal E; Witt C; Lozano MD; Schmidt B; Montuenga LM
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2665-72. PubMed ID: 20802023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
    Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
    Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies.
    Roden AC; Maleszewski JJ; Yi ES; Jenkins SM; Gandhi MJ; Scott JP; Aubry MC
    J Heart Lung Transplant; 2014 Dec; 33(12):1223-32. PubMed ID: 25149365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.
    Li J; Hu YM; Wang Y; Tang XP; Shi WL; Du YJ
    Int J Biol Markers; 2014 Dec; 29(4):e328-36. PubMed ID: 24519547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Roles and applications of liquid-based cytology in sputum samples from lung cancer patients].
    Cai L; Chen LZ; Chen Q; Wu LP; He LX; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):834-5. PubMed ID: 20193461
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
    Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
    J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.